Compare EVMN & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVMN | DC |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | United States |
| Employees | 48 | 41 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 843.8M |
| IPO Year | N/A | N/A |
| Metric | EVMN | DC |
|---|---|---|
| Price | $22.10 | $5.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $43.88 | $9.48 |
| AVG Volume (30 Days) | 308.6K | ★ 995.0K |
| Earning Date | 06-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.89 | $2.88 |
| 52 Week High | $33.20 | $7.25 |
| Indicator | EVMN | DC |
|---|---|---|
| Relative Strength Index (RSI) | 41.98 | 43.03 |
| Support Level | $21.39 | $5.32 |
| Resistance Level | $23.08 | $5.51 |
| Average True Range (ATR) | 1.42 | 0.29 |
| MACD | -0.21 | -0.06 |
| Stochastic Oscillator | 25.45 | 9.05 |
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Dakota Gold Corp is a gold exploration and development company focused on revitalizing the Homestake District in Lead, South Dakota. The company holds gold mineral properties surrounding the historic Homestake Mine and is advancing key projects, including the Richmond Hill Project.